PF-Atlas › Clinical Trials › NCT00570349
Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis
Nitric Oxide for Inhalation · Phase 1
Registry ID
NCT00570349
Phase
Phase 1
Status
Completed
Drug / intervention
Nitric Oxide for Inhalation
Sponsor
Mallinckrodt
Start
2004-07
About this trial
Nitric Oxide for Inhalation is evaluated in NCT00570349, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Mallinckrodt. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT00570349 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.